| Net Cash Provided by (Used in) Operating Activities |
$363,788,000 |
USD |
21% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$343,685,000 |
USD |
-31% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
100% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
116,791,263 |
shares |
33% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$20,103,000 |
USD |
-149% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$242,463,000 |
USD |
-28% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$44,143,000 |
USD |
123% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
250 |
shares |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
$189,167,000 |
USD |
47% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |